Syntaxin-1A Protein
Introduction
Syntaxin 1A Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
<div class="infobox infobox-protein"> [@sheng2020]
<div class="infobox-header">Syntaxin-1A</div> [@rizo2018]
<div class="infobox-row"><strong>Gene:</strong> [STX1A](/proteins/stx1a-protein)</div> [@giraud2021]
<div class="infobox-row"><strong>UniProt ID:</strong> [P61264](https://www.uniprot.org/uniprot/P61264)</div> [@zhou2022]
<div class="infobox-row"><strong>PDB ID:</strong> [3C98](https://www.rcsb.org/structure/3C98)</div>
<div class="infobox-row"><strong>Molecular Weight:</strong> ~35.6 kDa (288 amino acids)</div>
<div class="infobox-row"><strong>Subcellular Localization:</strong> Plasma membrane, synaptic vesicles</div>
<div class="infobox-row"><strong>Protein Family:</strong> SNARE family, Q-SNARE</div>
<div class="infobox-row"><strong>Associated Diseases:</strong> [Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), [ALS](/diseases/amyotrophic-lateral-sclerosis), Diabetes, Synaptic disorders</div>
</div>
Overview
...
Syntaxin-1A Protein
Introduction
Syntaxin 1A Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
<div class="infobox infobox-protein"> [@sheng2020]
<div class="infobox-header">Syntaxin-1A</div> [@rizo2018]
<div class="infobox-row"><strong>Gene:</strong> [STX1A](/proteins/stx1a-protein)</div> [@giraud2021]
<div class="infobox-row"><strong>UniProt ID:</strong> [P61264](https://www.uniprot.org/uniprot/P61264)</div> [@zhou2022]
<div class="infobox-row"><strong>PDB ID:</strong> [3C98](https://www.rcsb.org/structure/3C98)</div>
<div class="infobox-row"><strong>Molecular Weight:</strong> ~35.6 kDa (288 amino acids)</div>
<div class="infobox-row"><strong>Subcellular Localization:</strong> Plasma membrane, synaptic vesicles</div>
<div class="infobox-row"><strong>Protein Family:</strong> SNARE family, Q-SNARE</div>
<div class="infobox-row"><strong>Associated Diseases:</strong> [Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), [ALS](/diseases/amyotrophic-lateral-sclerosis), Diabetes, Synaptic disorders</div>
</div>
Overview
Syntaxin-1A is a neuronal Q-SNARE (Soluble N-ethylmaleimide-sensitive factor Attachment Protein REceptor) protein essential for synaptic vesicle fusion and neurotransmitter release[@sutton1998]. Encoded by the STX1A gene, this 288-amino acid protein is a critical component of the SNARE complex that mediates rapid exocytosis at synapses. Syntaxin-1A interacts with multiple proteins including SNAP-25, VAMP2, and Munc18-1 to orchestrate synaptic transmission, making it a protein of significant interest in neurodegenerative disease research.
Structure
Syntaxin-1A has a characteristic SNARE domain structure:
Domain Organization
- N-terminal Habc domain (residues 1-154): Three-helix bundle, regulates SNARE assembly
- Linker region (residues 155-189): Flexible connection
- SNARE motif (residues 190-266): Forms core SNARE complex
- Transmembrane anchor (residues 267-288): C-terminal membrane insertion
Structural Features
- Four-helix bundle in Habc domain (Habc = helical domains A, B, C)
- Polymerizable SNARE motif
- Calcium-binding site (distinct from synaptotagmin)
- Multiple protein interaction domains
Normal Function
Synaptic Vesicle Fusion
Syntaxin-1A is central to synaptic vesicle exocytosis:
- Forms ternary SNARE complex with SNAP-25 and VAMP2
- Mediates vesicle docking and priming
- Triggers rapid fusion pore opening
- Enables synchronous neurotransmitter release
Protein Interactions
| Partner | Interaction Type | Function |
|---------|-----------------|----------|
| SNAP-25 | SNARE complex | Synaptic vesicle fusion |
| VAMP2 | SNARE complex | Vesicle targeting |
| Munc18-1 | Regulatory | Vesicle priming |
| Munc13-1 | Regulatory | Priming activation |
| Complexin | Regulatory | Clamping |
| Synaptotagmin-1 | Calcium sensor | Triggering release |
Cellular Functions
- Regulates neurotransmitter release at excitatory and inhibitory synapses
- Controls synaptic vesicle pool size
- Modulates short-term plasticity
- Participates in endocytosis
Disease Involvement
Alzheimer's Disease
Syntaxin-1A is affected in AD through multiple mechanisms[@sheng2020]:
- Reduced expression in affected brain regions
- Dysregulation of SNARE complex assembly
- Effects on [Aβ](/proteins/amyloid-beta)-induced synaptic dysfunction
- Potential for therapeutic targeting
Parkinson's Disease
- Altered syntaxin-1A in PD brains
- Dopaminergic synapse dysfunction
- Potential role in LRRK2 pathogenesis
- Synaptic vesicle biology relevance
Amyotrophic Lateral Sclerosis (ALS)
- Motor neuron synaptic dysfunction
- SNARE complex alterations
- Excitotoxicity mechanisms
- Therapeutic targeting potential
Diabetes
- Syntaxin-1A regulates insulin secretion from pancreatic β-cells
- Implications for metabolic aspects of neurodegeneration
Therapeutic Implications
SNARE Complex Modulators
| Approach | Target | Development | Application |
|----------|--------|-------------|-------------|
| Botulinum toxins | SNAP-25 | FDA approved | Spasticity, dystonia |
| Small molecules | SNARE assembly | Research | Neuroprotection |
| Peptides | SNARE complex | Research | Synaptic modulation |
Research Strategies
- Enhancing SNARE complex stability
- Protecting against [Aβ](/proteins/amyloid-beta) toxicity
- Modulating synaptic vesicle dynamics
- Gene therapy approaches
Research Directions
SNARE Assembly: Mechanisms of complex formation
Neuroprotection: Syntaxin-1A as therapeutic target
Biomarkers: Synaptic dysfunction markers
Gene Therapy: AAV-mediated expressionSee Also
- [Proteins Index](/proteins)
- [STX1A Gene](/proteins/stx1a-protein)
- [SNAP-25 Protein](/proteins/snap-25-protein)
- [VAMP2 Protein](/proteins/vamp2-protein)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
External Links
- [UniProt: Syntaxin-1A](https://www.uniprot.org/uniprot/P61264)
- [PDB: Syntaxin-1A](https://www.rcsb.org/structure/3C98)
- [UniProt: STX1A](https://www.uniprot.org/uniprot/Q16623)
Background
The study of Syntaxin 1A Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
References
[Sutton RB, Fasshauer D, Jahn R, Brunger AT, Crystal structure of a SNARE complex involved in synaptic exocytosis (1998)](https://pubmed.ncbi.nlm.nih.gov/9827814/)
[Sheng J, Lv Z, Wang L, Zhou Y, Hui B, Dysfunction of syntaxin-1A in Alzheimer's disease (2020)](https://pubmed.ncbi.nlm.nih.gov/33252081/)
[Rizo J, Rosen MK, Gardner MK, Mechanisms of synaptic vesicle fusion (2018)](https://pubmed.ncbi.nlm.nih.gov/29500302/)
[Unknown, Giraud P, Jahn R, Südhof TC. Structure of the synaptosomal SNARE complex (2021)](https://pubmed.ncbi.nlm.nih.gov/33227612/)
[Zhou Y, Liu D, Chen Y, et al, SNARE proteins in synaptic dysfunction in Alzheimer's disease (2022)](https://pubmed.ncbi.nlm.nih.gov/35218934/)